|By Marketwired .||
|June 9, 2014 05:06 PM EDT||
TORONTO, ONTARIO -- (Marketwired) -- 06/09/14 -- Primera Bioscience Research Inc. ("Primera" or the "Company") is pleased to announce that further to its news release of May 20, 2014, it has completed the acquisition of Copenhagen Minerals Inc. ("CMI") in a share purchase transaction (the "Acquisition"). As a result, the Company now owns a 100% interest in the Storo Gold Project, an exploration project located in Greenland. The Company's name will be changed to "Greenland Resources Inc." to reflect this Acquisition.
The Company also announces the appointment of Ruben Shiffman, Jesper Kofoed, and Leonard Asper to the board of directors, the appointment of Mr. Shiffman as Chairman, and Mr. Kofoed as CEO, effective June 5, 2014. Dennis Waddington will continue as Chief Financial Officer and Corporate Secretary.
The Company also announces the resignations of Carolyn J. Rayfield as director and CEO, and of Maria Bruzzese and Christine Davison as directors. Primera thanks Ms. Rayfield, Ms. Bruzzese and Ms. Davison for their contributions to the Company during their respective tenures. We wish them well in their future endeavours.
Pursuant to the acquisition of CMI, the following individuals acquired common shares of the Company ("Shares") at a deemed price of $0.10 per Share: Mr. Shiffman of 80 Richmond St. W., Toronto, Ontario, M5H 2A4, acquired ownership of 6,550,000 Shares; Mr. Asper of 35 Hazelton Ave., 2nd Floor, Toronto, Ontario, M5R 2E3, acquired control over 5,550,000 Shares; and Mr. Kofoed of 80 Richmond St. W., Toronto, Ontario, M5H 2A4, acquired 4,550,000 Shares. None of Messrs. Shiffman, Asper, or Kofoed held shares of the Company prior to the Acquisition. Upon completion of the Acquisition, the respective shareholdings of Messrs. Shiffman, Asper, and Kofoed represent approximately 31.2%, 26.4%, and 21.6% of the outstanding Shares. Each of these Share acquisitions was completed for investment purposes, and none of Messrs. Shiffman, Asper, or Kofoed have any current intention to increase the beneficial ownership of, or control or direction over, securities of the Company. The Company is relying on an exemption from the prospectus requirement set out in section 2.16 of National Instrument 45-106, which relates to distributions in connection with a take-over bid.
ON BEHALF OF THE BOARD OF DIRECTORS
For more information, or to obtain a copy of the applicable securities reports filed in connection with the matters set forth above, please contact Ruben Shiffman.
Primera Bioscience Research Inc.
Dec. 10, 2016 02:45 PM EST Reads: 861
Dec. 10, 2016 02:45 PM EST Reads: 1,226
Dec. 10, 2016 02:30 PM EST Reads: 2,042
Dec. 10, 2016 01:45 PM EST Reads: 660
Dec. 10, 2016 01:00 PM EST Reads: 1,238
Dec. 10, 2016 01:00 PM EST Reads: 390
Dec. 10, 2016 12:45 PM EST Reads: 2,137
Dec. 10, 2016 12:30 PM EST Reads: 1,966
Dec. 10, 2016 12:15 PM EST Reads: 7,468
Dec. 10, 2016 12:15 PM EST Reads: 2,282
SYS-CON Events announced today that Dataloop.IO, an innovator in cloud IT-monitoring whose products help organizations save time and money, has been named “Bronze Sponsor” of SYS-CON's 20th International Cloud Expo®, which will take place on June 6-8, 2017, at the Javits Center in New York City, NY. Dataloop.IO is an emerging software company on the cutting edge of major IT-infrastructure trends including cloud computing and microservices. The company, founded in the UK but now based in San Fran...
Dec. 10, 2016 12:00 PM EST Reads: 785
Dec. 10, 2016 12:00 PM EST Reads: 1,094
Dec. 10, 2016 12:00 PM EST Reads: 2,400
Dec. 10, 2016 12:00 PM EST Reads: 2,413
Dec. 10, 2016 12:00 PM EST Reads: 493